Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Phase Distribution

Ph phase_2

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

3(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 23 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials

Showing 3 of 3

completedphase_2

Clinical Trials (3)

Showing 3 of 3 trials

NCT01069783Phase 2

Study of A3309 in Patients With Dyslipidemia

Completed

NCT01038687Phase 2

Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation

Completed

NCT01007123Phase 2

Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation

Completed

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3